End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
41.69
CNY
|
-0.88%
|
|
+6.82%
|
+20.28%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
11,035
|
7,513
|
6,637
|
6,293
|
7,516
|
-
|
-
|
Enterprise Value (EV)
1 |
11,035
|
7,513
|
6,637
|
6,293
|
7,516
|
7,516
|
7,516
|
P/E ratio
|
28.6
x
|
34.2
x
|
31.5
x
|
22.2
x
|
19
x
|
15.5
x
|
12.8
x
|
Yield
|
-
|
0.96%
|
0.95%
|
3.17%
|
3.77%
|
4.39%
|
-
|
Capitalization / Revenue
|
-
|
3.17
x
|
2.65
x
|
1.76
x
|
1.72
x
|
1.5
x
|
1.31
x
|
EV / Revenue
|
-
|
3.17
x
|
2.65
x
|
1.76
x
|
1.72
x
|
1.5
x
|
1.31
x
|
EV / EBITDA
|
-
|
-
|
16.7
x
|
10.7
x
|
9.72
x
|
8.2
x
|
8.12
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.21
x
|
2.65
x
|
2.88
x
|
2.91
x
|
2.61
x
|
2.31
x
|
Nbr of stocks (in thousands)
|
180,000
|
180,170
|
180,497
|
181,562
|
180,277
|
-
|
-
|
Reference price
2 |
61.31
|
41.70
|
36.77
|
34.66
|
41.69
|
41.69
|
41.69
|
Announcement Date
|
21-04-27
|
22-04-11
|
23-04-20
|
24-04-21
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
2,369
|
2,507
|
3,582
|
4,359
|
5,026
|
5,741
|
EBITDA
1 |
-
|
-
|
396.6
|
585.8
|
773.5
|
916.5
|
926
|
EBIT
1 |
-
|
289.8
|
265.1
|
282
|
443
|
580.7
|
717.5
|
Operating Margin
|
-
|
12.23%
|
10.57%
|
7.87%
|
10.16%
|
11.55%
|
12.5%
|
Earnings before Tax (EBT)
1 |
-
|
280.9
|
251.5
|
273.3
|
440.7
|
578
|
712.5
|
Net income
1 |
257.4
|
231.8
|
212.3
|
281
|
399
|
488.3
|
591.5
|
Net margin
|
-
|
9.79%
|
8.47%
|
7.85%
|
9.15%
|
9.72%
|
10.3%
|
EPS
2 |
2.140
|
1.220
|
1.168
|
1.558
|
2.197
|
2.690
|
3.255
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.4000
|
0.3500
|
1.100
|
1.570
|
1.830
|
-
|
Announcement Date
|
21-04-27
|
22-04-11
|
23-04-20
|
24-04-21
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
9.77%
|
8.12%
|
12.1%
|
15.6%
|
17.1%
|
18%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
5.3%
|
-
|
7%
|
7.75%
|
8.6%
|
Assets
1 |
-
|
-
|
4,003
|
-
|
5,700
|
6,301
|
6,878
|
Book Value Per Share
2 |
-
|
13.00
|
13.90
|
12.10
|
14.40
|
15.90
|
18.10
|
Cash Flow per Share
2 |
-
|
1.890
|
2.460
|
2.130
|
3.260
|
4.160
|
3.370
|
Capex
1 |
-
|
524
|
294
|
449
|
310
|
310
|
310
|
Capex / Sales
|
-
|
22.13%
|
11.71%
|
12.53%
|
7.11%
|
6.17%
|
5.4%
|
Announcement Date
|
21-04-27
|
22-04-11
|
23-04-20
|
24-04-21
|
-
|
-
|
-
|
Last Close Price
41.69
CNY Average target price
41.67
CNY Spread / Average Target -0.06% Consensus |
1st Jan change
|
Capi.
|
---|
| +20.28% | 1.04B | | +16.80% | 8.43B | | +15.02% | 6.82B | | -4.77% | 3.77B | | -6.75% | 3.74B | | +4.41% | 1.44B | | -30.34% | 1.06B | | -12.85% | 890M | | -15.63% | 812M | | +2.88% | 732M |
Special Foods & Wellbeing Products
|